Clinical Trial: Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466927) titled 'Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases' on March 09.

Brief Summary: This is a prospective, open-label, phase II platform trial. The purpose of this study is to test the safety and effectiveness of multi-mode thermal therapy combined with immunotherapy in patients with HER2-negative breast cancer with liver metastases who had previously received systemic therapy

Study Start Date: March 15

Study Type: INTERVENTIONAL

Condition: HER2-negative Breast Cancer

Intervention: DRUG: SHR-A1811

A HER2-directed ADC, via intravenous (into the vein) ...